Transcutaneous spinal stimulation to stabilize blood pressure after spinal cord injury
Official title: Neuromodulation of Blood Pressure Using Transcutaneous Spinal Stimulation in Chronic Spinal Cord Injury
Run by Kessler Foundation · NCT05725499 · Data updated 2026-11-12
This will test whether noninvasive transcutaneous spinal cord stimulation can raise and stabilize blood pressure in people with chronic high-level spinal cord injuries who experience orthostatic hypotension.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 5 (estimated) |
| Sponsor | Kessler Foundation Academic / other |
| Locations | 1 site (West Orange, New Jersey) |
| Status | Recruiting |
| Started | February 1, 2023 |
| Main results expected | August 1, 2026 |
| Study ends | August 1, 2026 |
| Registry record updated | September 2, 2025 |
| Trial ID | NCT05725499 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people at least six months post-spinal cord injury at T6 or above (ASIA A–D) who experience baseline hypotension or clinically significant drops in systolic blood pressure with position changes.
✕Probably not a fit
People with implanted stimulators or pacemakers, significant cardiac conduction disease, ventilator dependence, active serious illness, pregnancy, or those without orthostatic hypotension are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will apply transcutaneous spinal cord stimulation at various thoracic sites and with different stimulation settings while participants undergo controlled tilt-table tests to 70 degrees. Blood pressure responses will be compared with and without stimulation to determine which sites and parameters best prevent drops in blood pressure on upright posture. The protocol also includes repeated stimulation sessions to see whether repeated exposure (training) improves blood pressure stability over time. Participants are adults with chronic spinal cord injury at or above T6 who have documented orthostatic hypotension or related symptoms.
Why it matters
Potential benefit: If successful, this could offer a noninvasive way to reduce dizziness, fainting, and long-term cardiovascular risk by preventing drops in blood pressure after spinal cord injury.
How similar studies have gone: Epidural spinal stimulation has shown promising results for cardiovascular control and one small report of transcutaneous stimulation restored cardiovascular function, but broader evidence for scTS is limited.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Spinal cord injury for greater than or equal to 6 months * Injury level ≥ T6 (thoracic level) * American Spinal Injury Association (ASIA) Impairment Scale (AIS) A-D * Exhibits at least one of the following hypotensive symptoms: 1. Baseline hypotension - resting supine or seated systolic blood pressure(SBP) \< 90mmHg; 2. SBP drop ≥ 20 mmHg within 5 minutes of assuming seated position; 3. Symptoms of orthostasis with a drop of SBP (\<90mmHg) from supine to sitting Exclusion Criteria: * Current illness (infection, a pressure injury that might interfere with the intervention, a recent diagnosis of DVT/PE, etc.) * Ventilator-dependent * History of implanted brain/spine/nerve stimulators * Cardiac pacemaker/defibrillator or intra-cardiac lines * Significant coronary artery or cardiac conduction disease, a recent history of myocardial infarction * Insufficient mental capacity to understand and independently provide consent * Pregnancy * Cancer * Deemed unsuitable by study physician
Where it's running
-
Kessler Foundation
West Orange, New Jersey, United States Recruiting
Study contacts
- Principal investigator: Gail F Forrest, Phd — Kessler Foundation
- Study coordinator: LeighAnn Martinez, BA
- Email: lmartinez@kesslerfoundation.org
- Phone: (973)324-3557
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Transcutaneous spinal stimulation to improve blood pressure after a recent spinal cord injury
We will try a noninvasive spinal stimulation to see if it raises and steadies blood pressure in people 7–30 days after a thoracic spinal cord injury who have low blood pressure or dizziness when sitting up.
-
Combining testosterone therapy with walking training to improve health after spinal cord injury
This study is testing if combining testosterone therapy with walking training can help men with spinal cord injuries who have low testosterone and trouble walking improve their health and mobility.
-
Registering medical data and care outcomes for ALS, SMA, and other motor disorders
This registry slowly collects routine-care information from adults with ALS, SMA, or other motor disorders to see how they’re treated and how care affects outcomes.
-
NG004 for incomplete cervical spinal cord injury
This trial tests NG004 versus placebo to see if it is safe and helps motor function and daily life in adults with acute incomplete cervical spinal cord injury.
-
Portable EEG to triage suspected stroke patients in ambulances
This trial will test whether a portable dry‑electrode EEG headset (StrokePointer) can detect large vessel occlusion strokes in adults with suspected acute stroke so ambulance crews can take them directly to hospitals that perform thrombectomy.
-
Using deep brain stimulation to improve speech and arm function after stroke
This study is testing if deep brain stimulation can help improve hand movement and speech in people who have had a stroke.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.